U.S. flag An official website of the United States government

On Oct. 1, 2024, the FDA began implementing a reorganization impacting many parts of the agency. We are in the process of updating FDA.gov content to reflect these changes.

  1. Home
  2. Inspections, Compliance, Enforcement, and Criminal Investigations
  3. Compliance Actions and Activities
  4. Warning Letters
  5. Crystal Canyon Vapes LLC - 632020 - 09/12/2022
  1. Warning Letters

CLOSEOUT LETTER

Crystal Canyon Vapes LLC MARCS-CMS 632020 —

Delivery Method:
VIA Electronic Mail
Reference #:
RW2201765
Product:
Tobacco

Recipient:
Recipient Name
Marc Foumberg
Crystal Canyon Vapes LLC

United States

service@ccvapes.com
Issuing Office:
Center for Tobacco Products

United States


Dear Marc Foumberg:

The United States Food and Drug Administration’s (FDA) Center for Tobacco Products has completed an evaluation of your corrective actions included in your responses dated May 9, 2022, June 14, 2022, and July 12, 2022, in response to our Warning Letter dated April 22, 2022. Based on our evaluation, it appears that you have taken steps to address the violations contained in the Warning Letter regarding your website https://www.ccvapes.com.

This letter does not relieve you or your firm from the responsibility of taking all necessary steps to ensure sustained compliance with each applicable provision of the Federal Food, Drug, and Cosmetic Act (FD&C Act) and FDA’s implementing regulations or with other relevant legal authority. Please note that if your firm is found to be in violation of the FD&C Act, 21 U.S.C. § 301 et seq., Chapter IX, relating to tobacco products including the tobacco regulations in 21 C.F.R. Parts 1140, 1141, and 1143 in the future, this may lead to regulatory action, including, but not limited to, civil money penalties, seizure, and/or injunction.

Sincerely,
/S/
David Rice
Branch Chief
Division of Promotion, Advertising, and Labeling
Office of Compliance and Enforcement
Center for Tobacco Products


1&1 Internet Inc.
dataprivacyprotected@ionos.de

IONOS SE
abuse@ionos.com

Back to Top